A few suggestions for the Meditech Advisory Board

[bmi...@bdh-boz.com]

Here's a list of suggestions I submitted to Charlie Downs to forward
to the Meditech Advisory Board. Feel free to add to the list. Becky
*****************************************************************************************

PHA: If you change a PHA drug to Additive =N, it will not warn you if
you have that drug used in any existing order sets/strings as an
Additive.

RXM: Need to be able to map frequencies from FDB to Meditech
convention sigs.

PHA: Need to be able to use the same NDC for a PHA Formulary drug as
for a PHA Retail drug (RXM). Should be a “warning” only not a hard
stop.

PHA: EMAR CDS’s need to be able to be skipped if the dose will be “not
given”

PHA: Need to be able to see reassessment queries and responses on EMAR
Administration Report.

PHA: Need to have fields to place a second EMAR Reassessment CDS on
page 4 of drug dictionary.

RXM: Need to have internal code for each individual POEM string so
that if a string is edited, the system retains edits and does not
reload the string again.